Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

HalioDx S.A.S.

HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies. Immunoscore® proprietary technology, pioneered by Jérôme Galon at the Cordeliers Research Center, Paris, France, integrates immunohistochemistry combined with sophisticated algorithm and advanced imaging analysis, enabling extraction of spatially-organized tissue molecular information. Immunoscore® is a platform for many cancers, as immune response to tumor is a key hallmark of disease progression. HalioDx collaborates with renowned international clinical groups to support clinical utility and ensure rigorous performance validation of its assays in selected cancer indications. HalioDx has an experienced team of more than 135 employees, CLIA-certified laboratories and compliant facilities in Europe and in the US to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies. The company co-founded the European immunology cluster Marseille Immunopôle (MI). *

 

Period Start 2015-03-23 established (s-off)
  Predecessor Qiagen Marseille S.A.
Products Industry molecular diagnostics
  Industry 2 Immunoscore® cancer prognosis tool
Persons Person Fert, Vincent (HalioDx 201503– CEO + CO-founder before Ipsogen 200708– President + CEO)
  Person 2 Galon, Jérôme (INSERM 201507 + Co-Founder of HalioDx)
     
Region Region Marseille
  Country France
  Street 163 avenue de Luminy
Luminy Biotech Entreprises, Case 923
  City 13288 Marseille Cedex 09
  Tel +33-4-9129-3090
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2019-04-19)
     
    * Document for �About Section�: HalioDx S.A.S.. (4/19/19). "Press Release: HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore Available in China". Marseille.
     
   
Record changed: 2021-06-02

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Veracyte (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top